Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial
Ray Y. Chen(National Institute of Allergy and Infectious Diseases), Rodney Dawson(University of Cape Town), Qi Jiang(Fudan University), Stephanus T. Malherbe(South African Medical Research Council), Mark Hatherill(South African Tuberculosis Vaccine Initiative), Laura E. Via(National Institutes of Health), Bronwyn Smith(South African Medical Research Council), Michael Tartakovsky(National Institutes of Health), André G. Loxton(South African Medical Research Council), Clifton E. Barry(National Institutes of Health), Lori E. Dodd(National Institutes of Health), Gerhard Walzl(South African Medical Research Council), Hongfei Duan(Beijing Chest Hospital), Taeksun Song(University of Cape Town), Andreas H. Diacon(Stellenbosch University), Robert J. Wilkinson(University of Cape Town), Friedrich Thienemann(University of Cape Town), Xiaowei Jin(China National Environmental Monitoring Center), Hong Zhu, Michèle Tameris(University of Cape Town), Alex Rosenthal(National Institutes of Health), Michael Duvenhage(National Institutes of Health), Xin Liu(Hospital of Stomatology, Sun Yat-sen University), Jill Winter(Catalysis Foundation for Health), Kriti Arora(National Institutes of Health), Xing Jin(Henan Provincial Center for Disease Control and Prevention), Qian Gao(Fudan University), Lisa C. Goldfeder(National Institute of Allergy and Infectious Diseases), Zhenya Ma(Kaifeng University), Christopher Whalen(National Institutes of Health), David Alland(Rutgers, The State University of New Jersey), Ying Cai(National Institutes of Health), Guolong Zhang(Henan Provincial Center for Disease Control and Prevention), Lili Liang(Stellenbosch University), Shouguo Pan
Cited by 45
Related Papers
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
|The Lancet Infectious Diseases|2017|688
DBAASP v3: database of antimicrobial/cytotoxic activity and structure of peptides as a resource for development of new therapeutics
|Nucleic Acids Research|2020|667
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
|The Lancet|2018|639
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
|Nature|2022|622
Diagnosis of Childhood Tuberculosis and Host RNA Expression in Africa
|New England Journal of Medicine|2014|392